Could metabolic risk factors contribute to the development of cervical cancer?
Open Access
- 18 December 2019
- journal article
- Published by Heighten Science Publications Corporation in Annals of Clinical Endocrinology and Metabolism
- Vol. 3 (1), 001-006
- https://doi.org/10.29328/journal.acem.1001011
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Serum Lipid Profiles and Cancer Risk in the Context of Obesity: Four Meta-AnalysesJournal of Cancer Epidemiology, 2013
- ‘Metabolically healthy obesity’: Origins and implicationsMolecular Aspects of Medicine, 2012
- HDL functionalityCurrent Opinion in Lipidology, 2012
- Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me–Can)Gynecologic Oncology, 2012
- Mature breast adipocytes promote breast cancer cell motilityExperimental and Molecular Pathology, 2012
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- The Role of High-Density Lipoproteins in Reducing the Risk of Vascular Diseases, Neurogenerative Disorders, and CancerCholesterol, 2010
- Enzymatic activity of the human 1-acylglycerol-3-phosphate-O-acyltransferase isoform 11: upregulated in breast and cervical cancersJournal of Lipid Research, 2010
- Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasiaJournal of Gynecologic Oncology, 2010
- Determinants of plasma HDL concentrations and reverse cholesterol transportCurrent Opinion in Cardiology, 2006